Health & clinical servicesAwardedThe buyer says it suits small firms

ACT2 Study

A tender from The University of Birmingham.

Public bodyThe University of Birmingham
WhereBirmingham, West Midlands
Value£515k
Published14 Jul 2025
How it was boughtDirect award: given to a chosen firm without a competition.
Contract1 Aug 2026
Won byNot named in the notice
Awarded for£515k
Awarded on14 Jul 2025
BidsNot published

Official notice on Find a Tender ↗

Similar open tenders nearby

This tender has closed. Open tenders like it, in Birmingham:

Get alerts for tenders like this. Start free and get 7 days of Professional, with job alerts, no card. After that, searching every tender stays free with one weekly job alert; daily alerts are from £19 a month.

Get alerts for tenders like thisSearch all tenders like this

What the notice says

University of Birmingham (UoB) is the sponsor of ACT2 (Allogeneic Chondrocyte Therapy - A phase 2a study), an MRC funded project (MR/V027670/1). The study commenced in 2021 with the aim to develop and manufacture an allogeneic chondroprogenitor cell therapy from fresh osteochondral allografts in order to treat cartilage lesions in a single surgery. The study requires a manufacturing facility that can work with the research team to develop and validate the manufacturing process of the cell therapy product to a standard that can gain MHRA approval and thus enable the commencement of a Phase 2a human trial. Due to unforeseen circumstances, previously contracted GMP manufacturers are no longer able to manufacture the cell therapy product and, thus an alternative manufacturing facility is required expeditiously. The UoB team must operate within the restrictions placed upon them by the funder and the current project plan. In addition to this, the administrative burden as a consequence of BREXIT makes the use of a UK laboratory the only viable option. The Newcastle Advanced Therapies Facility has the unique requirements to deliver the project within the financial and time restrictions facing the project.

Past health & clinical services jobs at The University of Birmingham

The latest of the 41 contracts in this trade it awarded in the last five years, with who won them.

ContractWon byValueBidsAwarded
Reagent Rental Contract for Diagnostic Service on the BD FACS Canto II analysers, Lyse Wash Assistants and BD FACS Lyric.Not named£36m–14 Nov 2025
MEGIN Elekta Service ContractNot named£360k–15 Jul 2025
C-Trap Dymo 400. Optical Tweezers-Fluorescence MicroscopeNot named£650k–11 Jul 2025
Anatomage Virtual Cadaver Table with 5 real-human cadaversAnatomage Inc£137k–1 Apr 2025
BioRad NGC Discover 10 Pro Chromatography System and accessories Quotation QQ637388-CPQ25Bio-rad Laboratories Limited£75k–10 Feb 2025
DHA tablets for Miscarriage MAMS trial, 28 capsules per packStrides Pharma UK Ltd£62k–20 Jan 2025
Flow Cytometry Unit Bundle Service ContractBecton, Dickinson U.K. Limited£434k–16 Jan 2025
Glo-BNHL Central Review of Imaging and Clinical DataMedidata Solutions International Ltd£685k–13 Dec 2024

2 of the 41 health & clinical services contracts The University of Birmingham awarded in the last five years published a bid count: too few to say what is typical.

The University of Birmingham's health & clinical services contracts ending soon

With who holds them now, over the next 18 months.

ContractHeld byValueEnds
Reagent Rental Contract for Diagnostic Service on the BD FACS Canto II analysers, Lyse Wash Assistants and BD FACS Lyric.Not named£36m26 Nov 2027

More: All of The University of Birmingham’s tenders · Tenders in Birmingham · Tenders in the West Midlands

Tenders and awards from Find a Tender, Contracts Finder, Public Contracts Scotland and Sell2Wales; contracts ending also from councils' own contract registers. Contains public sector information licensed under the Open Government Licence v3.0.